Lincoln Alternative Strategies LLC - 20 Aug 2025 SCHEDULE 13G Report for Calidi Biotherapeutics, Inc. Common Stock, $0.0001 par value (CLDI)

Filing Manager: Lincoln Alternative Strategies LLC
Reporting Manager: Lincoln Alternative Strategies LLC
Security: Calidi Biotherapeutics, Inc. Common Stock, $0.0001 par value
Symbol: CLDI
Shares outstanding: 5,048,409 shares
Disclosed Ownership: 730,000 shares
Ownership: 14%
Form type: SCHEDULE 13G
Filing time: 27 Aug 2025, 09:15:04 UTC
Date of event: 20 Aug 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Lincoln Alternative Strategies LLC	14%	730,000	730,000	0	/s/ Stephen Temes	Stephen Temes/Managing Member